Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 2806 AL 2820

Developing Effective Alzheimer's Disease Therapies: Clinical Experience and Future Directions

Elmaleh DR, Farlow MR, Conti PS, Tompkins RG, Kundakovic L, Tanzi RE.

J Alzheimers Dis. 2019;71(3):715-732. doi: 10.3233/JAD-190507.

A Pilot Study of Exenatide Actions in Alzheimer's Disease

Mullins RJ, Mustapic M, Chia CW, Carlson O, Gulyani S, Tran J, Li Y, Mattson MP, Resnick S, Egan JM, Greig NH, Kapogiannis D.

Curr Alzheimer Res. 2019;16(8):741-752. doi: 10.2174/1567205016666190913155950.

Evaluation of the diagnostic value of peripheral BDNF levels for Alzheimer's disease and mild cognitive impairment: results of a meta-analysis

Xie B, Zhou H, Liu W, Yu W, Liu Z, Jiang L, Zhang R, Cui D, Shi Z, Xu S.

Int J Neurosci. 2020 Mar;130(3):218-230. doi: 10.1080/00207454.2019.1667794. Epub 2019 Sep 24.

Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment

Chandra A, Valkimadi PE, Pagano G, Cousins O, Dervenoulas G, Politis M; Alzheimer's Disease Neuroimaging Initiative.

Hum Brain Mapp. 2019 Dec 15;40(18):5424-5442. doi: 10.1002/hbm.24782. Epub 2019 Sep 14.

Affective symptoms and AT(N) biomarkers in mild cognitive impairment and Alzheimer's disease: A systematic literature review

Banning LCP, Ramakers IHGB, Deckers K, Verhey FRJ, Aalten P.

Neurosci Biobehav Rev. 2019 Dec;107:346-359. doi: 10.1016/j.neubiorev.2019.09.014. Epub 2019 Sep 13.

Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer's disease

Hadoux X, Hui F, Lim JKH, Masters CL, Pébay A, Chevalier S, Ha J, Loi S, Fowler CJ, Rowe C, Villemagne VL, Taylor EN, Fluke C, Soucy JP, Lesage F, Sylvestre JP, Rosa-Neto P, Mathotaarachchi S, Gauthier S, Nasreddine ZS, Arbour JD, Rhéaume MA, Beaulieu S, Dirani M, Nguyen CTO, Bui BV, Williamson R, Crowston JG, van Wijngaarden P.

Nat Commun. 2019 Sep 17;10(1):4227. doi: 10.1038/s41467-019-12242-1.

Perspective: Clinical relevance of the dichotomous classification of Alzheimer's disease biomarkers: Should there be a "gray zone"?

McRae-McKee K, Udeh-Momoh CT, Price G, Bajaj S, de Jager CA, Scott D, Hadjichrysanthou C, McNaughton E, Bracoud L, Ahmadi-Abhari S, de Wolf F, Anderson RM, Middleton LT; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2019 Oct;15(10):1348-1356. doi: 10.1016/j.jalz.2019.07.010. Epub 2019 Sep 26.

Cerebral Amyloid Angiopathy, Alzheimer's Disease and MicroRNA: miRNA as Diagnostic Biomarkers and Potential Therapeutic Targets

Weldon Furr J, Morales-Scheihing D, Manwani B, Lee J, McCullough LD.

Neuromolecular Med. 2019 Dec;21(4):369-390. doi: 10.1007/s12017-019-08568-0. Epub 2019 Oct 4.

Plasma Clusterin as a Potential Biomarker for Alzheimer's Disease-A Systematic Review and Meta-analysis

Shi X, Xie B, Xing Y, Tang Y.

Curr Alzheimer Res. 2019;16(11):1018-1027. doi: 10.2174/1567205016666191024141757.

Cognitive Decline and Alzheimer's Disease in Old Age: A Sex-Specific Cytokinome Signature

Boccardi V, Paolacci L, Remondini D, Giampieri E, Poli G, Curti N, Cecchetti R, Villa A, Ruggiero C, Brancorsini S, Mecocci P.

J Alzheimers Dis. 2019;72(3):911-918. doi: 10.3233/JAD-190480.

Detection of amyloid beta peptides in body fluids for the diagnosis of alzheimer's disease: Where do we stand?

Veerabhadrappa B, Delaby C, Hirtz C, Vialaret J, Alcolea D, Lleó A, Fortea J, Santosh MS, Choubey S, Lehmann S.

Crit Rev Clin Lab Sci. 2020 Mar;57(2):99-113. doi: 10.1080/10408363.2019.1678011. Epub 2019 Oct 29.

Saliva, an easily accessible fluid as diagnostic tool and potent stem cell source for Alzheimer's Disease: Present and future applications

Reale M, Gonzales-Portillo I, Borlongan CV.

Brain Res. 2020 Jan 15;1727:146535. doi: 10.1016/j.brainres.2019.146535. Epub 2019 Oct 25.

Cerebrospinal fluid proteomics and biological heterogeneity in Alzheimer's disease: A literature review

Wesenhagen KEJ, Teunissen CE, Visser PJ, Tijms BM.

Crit Rev Clin Lab Sci. 2020 Mar;57(2):86-98. doi: 10.1080/10408363.2019.1670613. Epub 2019 Nov 7.

Medium-chain triglycerides improved cognition and lipid metabolomics in mild to moderate Alzheimer's disease patients with APOE4(-/-): A double-blind, randomized, placebo-controlled crossover trial

Xu Q, Zhang Y, Zhang X, Liu L, Zhou B, Mo R, Li Y, Li H, Li F, Tao Y, Liu Y, Xue C.

Clin Nutr. 2020 Jul;39(7):2092-2105. doi: 10.1016/j.clnu.2019.10.017. Epub 2019 Oct 22.

When Does Alzheimer's Disease Really Start? The Role of Biomarkers

Lloret A, Esteve D, Lloret MA, Cervera-Ferri A, Lopez B, Nepomuceno M, Monllor P.

Int J Mol Sci. 2019 Nov 6;20(22):5536. doi: 10.3390/ijms20225536.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias